InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-11.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Litvack Frank, Director. Director active across 1 company, notably Capricor Therapeutics, INC.. Cumulatively, 6 filings have been logged. History available since 3 January 2022. The latest transaction was filed on 13 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Litvack Frank
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
3,937 shares@ US$1.390.0003% mcap1.2% of flowCommon StockSEC:0001310715-26-000004:0
25,000 shares@ US$1.396.9% of flowCommon StockSEC:0001415889-25-006736:0
20,391 shares@ US$1.104.4% of flowCommon StockSEC:0001415889-24-028337:0
20,748 shares@ US$1.395.4% of flowCommon StockSEC:0001415889-23-012326:0
14,027 shares@ US$1.393.8% of flowCommon StockSEC:0001415889-23-003083:0
154,543 shares@ US$1.390.011% mcap48.8% of flowCommon StockSEC:0001415889-22-000284:0
6 of 6 declarations
About Litvack Frank
Frank Litvack is a Board Member of Capricor Therapeutics, Inc., a biotechnology company. As a board member, he participates in overseeing the company's activities and making strategic decisions. His expertise in the biotechnology field is valuable for guiding Capricor's initiatives.
